Pneumocystis: Clinical Trials

3 trials for Pneumocystis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1

Follow Pneumocystis: new trials by email Literature Review of Pneumocystis trials Research Report on Pneumocystis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
trimethoprim-sulfamethoxazole - Pneumocystis, Pneumocystis Pneumonia
Phase 3RecruitingTodd C. Lee MD MPH FIDSA4162025-11-282026-02-20
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Rezafungin for Injection, Posaconazole, Fluconazole - Candidemia, Mycoses
Phase 3CompletedMundipharma Research Limited6022020-05-112026-04-13
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients
Methylprednisolone, Placebo - Pneumocystis, Steroids
Phase 3UnknownAssistance Publique - Hôpitaux de Paris2222017-02-152020-10-06

Narrower conditions

Pneumonia, Pneumocystis (3)  ·  Infections (2)  ·  Candidemia (1)  ·  Candidiasis (1)  ·  Candidiasis, Invasive (1)  ·  Fungemia (1)  ·  Hematologic Neoplasms (1)  ·  Inflammation (1)  ·  Invasive Fungal Infections (1)  ·  Mycoses (1)  ·  Neoplasms (1)  ·  Pathologic Processes (1)  ·  Pneumocystis Infections (1)  ·  Pneumonia (1)  ·  Sepsis (1)

Broader conditions

Bacterial Infections and Mycoses (3)  ·  Lung Diseases (3)  ·  Lung Diseases, Fungal (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Mycoses (2)  ·  Pneumocystis Infections (2)  ·  Pneumonia (2)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Infections (1)  ·  Neoplasms by Site (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Shock (1)

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination (2)  ·  Fluconazole (1)  ·  Injections (1)  ·  Methylprednisolone (1)  ·  Off-Label Use (1)  ·  Rezafungin (1)  ·  posaconazole (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Mundipharma Research Limited (1)  ·  Todd C. Lee MD MPH FIDSA (1)

Countries

Canada (2)  ·  France (2)  ·  Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Elie Azoulay, MD PHD (1)  ·  Emily G McDonald, MD MSc (1)  ·  Laura Cox, PhD (1)  ·  Todd C Lee, MD MPH FIDSA (1)  ·  Virginie Lemiale, MD (1)

Results publications

PMID 33438477, PMID 35863836, PMID 37773627, PMID 40652952, PMID 42558999

NIH funding

2016 (1), 2017 (1)